Search

Search Constraints

You searched for: Author/Creator Gluz, Oleg

Search Results

11. The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer. (November 2020)

12. The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. (October 2021)

13. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. (14th November 2021)